Kadmon Holdings (Kadmon Holdings) Pretax Margin % : -224.69% (As of Sep. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Kadmon Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Kadmon Holdings's Pre-Tax Income for the three months ended in Sep. 2021 was $-33.04 Mil. Kadmon Holdings's Revenue for the three months ended in Sep. 2021 was $14.71 Mil. Therefore, Kadmon Holdings's pretax margin for the quarter that ended in Sep. 2021 was -224.69%.

The historical rank and industry rank for Kadmon Holdings's Pretax Margin % or its related term are showing as below:

KDMN' s Pretax Margin % Range Over the Past 10 Years
Min: -3923.78 Med: -799.9 Max: -67.76
Current: -745.02

KDMN's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -172.84 vs KDMN: -745.02

Kadmon Holdings Pretax Margin % Historical Data

The historical data trend for Kadmon Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadmon Holdings Pretax Margin % Chart

Kadmon Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Pretax Margin %

Get a 7-Day Free Trial

-799.90

-651.46

-3,923.78

-1,203.57

-1,316.30

Kadmon Holdings Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Pretax Margin %	Get a 7-Day Free Trial															-5,021.63	-4,559.35	-5,040.50	-15,403.55	-224.69

Competitive Comparison of Kadmon Holdings's Pretax Margin %

For the Biotechnology subindustry, Kadmon Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kadmon Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadmon Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Kadmon Holdings's Pretax Margin % falls into.

Kadmon Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Kadmon Holdings's Pretax Margin for the fiscal year that ended in Dec. 2020 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2020 )	/	Revenue (A: Dec. 2020 )
	=	-109.095	/	8.288
	=	-1,316.30 %

Kadmon Holdings's Pretax Margin for the quarter that ended in Sep. 2021 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2021 )	/	Revenue (Q: Sep. 2021 )
	=	-33.043	/	14.706
	=	-224.69 %

Kadmon Holdings (NAS:KDMN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Kadmon Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Kadmon Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadmon Holdings (Kadmon Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadmon Holdings Inc (NAS:KDMN) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

450 East 29th Street, New York, NY, USA, 10016

Website

https://www.kadmon.com

Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.

Executives

Harlan Waksal	director, officer: President, CEO	WAKSAL CONSULTING LLC, 7 NORTH WILLOW STREET, SUITE 6, MONTCLAIR NJ 07042
Nancy Miller-rich	director	C/O INTERCEPT PHARMACEUTICALS, INC., 10 HUDSON YARDS, 37TH FL, NEW YORK NY 10001
Cynthia Schwalm	director	C/O G1 THERAPEUTICS, 700 PARK OFFICES DR, SUITE 200, P.O. BOX 110341, RESEARCH TRIANGLE PARK NC 27709
Arthur S Kirsch	director	7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4
David E Cohen	director	3160 PORTER DRIVE, PALO ALTO CA 94304
Eugene Bauer	director	C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016
Tasos Konidaris	director	103 JFK PARKWAY, SHORT HILLS NJ 07078
John L Ryan	officer: Executive Vice President, CMO	C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Steven Meehan	officer: EVP, Chief Financial Officer	450 E. 29TH STREET NEW YORK NY 10016
Kyle Carver	officer: Principal Accounting Officer, Controller	450 EAST 29TH STREET NEW YORK NY 10016
Gregory S. Moss	officer: EVP, General Counsel, Chief Compliance Officer	450 EAST 29TH STREET, 16TH FLOOR, NEW YORK NY 10016
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc	other: Former 10% owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Steven N. Gordon	officer: Exec VP, GC, Chief Admin, Comp	C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016